AzTrials
AzTrials

Non-inferiority, in Terms of Extubation Failure, Continuation of Enteral Nutrition Before Extubation Versus Gastric Vacuity Peri-extubationAMBROISIENCT03335345

Non-inferiority Study of the Pursuit of Enteral Nutrition Compared to a Strategy of Gastric Emptiness Peri-extubation. Cluster Randomized Trial

A study testing maintaining calorie intake and maximum gastric vacuity in people with Non-inferiority, in Terms of Extubation Failure, Continuation of Enteral Nutrition Before Extubation Versus Gastric Vacuity Peri-extubation, run by Centre Hospitalier le Mans at 22 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Approximately 50 to 60% of ICU patients are subjected to invasive mechanical ventilation-through a tracheal tube. Extubation consists of a key moment for the patient on the road to recovery (1). The extubation failure, is a major disease event. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
maintaining calorie intake and maximum gastric vacuity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,148 participants
Where
22 sitesin 2 countries
Study dates
5 Apr 2018to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hospitalized patient in intensive care
  • Invasive artificial ventilation for at least 48h at the time of extubation
  • Prepyloric enteral feeding for at least 24 hours at the time of extubation
  • Age ≥ 18 years

Who cannot join

  • tutorship or curatorship
  • Pregnant, parturient or nursing woman
  • Patient not affiliated to a social security scheme
  • Tracheotomized patient
  • Post-pyloric enteral-fed patient (naso-jejunal tube)
  • Patient already included in this study

Trial locations and contacts

22 sites in 2 countries.

22 sites in 2 countries

France21 sites
  • Réanimation Médicale-CHU ANGERS

    Angers, 49000

  • Réanimation médico-chirurgicale-CH BLOIS

    Blois, 41000

  • Réanimation Chirurgicale-CHU BREST

    Brest, 29200

  • Réanimation Médicale CHU BREST

    Brest, 29200

  • Réanimation polyvalente-CH CHARTRES

    Chartres, 28000

  • Réanimation polyvalente-CH CHOLET

    Cholet, 49280

  • Réanimation polyvalente-CH DREUX

    Dreux, 28100

  • Réanimation polyvalente-Centre Hospitalier Départemental Vendée

    La Roche-sur-Yon, 85000

  • Réanimation médico-chirurgicale- CH LE MANS

    Le Mans, 72000

  • Réanimation-CH de Pays de MORLAIX

    Morlaix, 29600

  • Réanimation Chirugicale 2- CHU NANTES

    Nantes, 44000

  • Réanimation Médicale-CHU NANTES

    Nantes, 44000

  • Médecine Intensive Réanimation-CH ORLEANS

    Orléans, 45000

  • Réanimation médico-chirurgicale-CH PARIS ST JOSEPH

    Paris, 75014

  • Réanimation Médicale-CHU POITIERS

    Poitiers, 86000

  • Réanimation et Soins Continus-CHI de CORNOUAILLE

    Quimper, 29000

  • Réanimation Médicale-CHU RENNES

    Rennes, 35000

  • Réanimation polyvalente-CH SAINT BRIEUC

    Saint-Brieuc, 22000

  • Réanimation polyvalente-CHG SAINT NAZAIRE

    Saint-Nazaire, 44600

  • Réanimation Chirurgicale-CHRU TOURS

    Tours, 37000

  • Réanimation Médicale-CHRU TOURS

    Tours, 37000

Other trials in France

Guadeloupe1 site
  • Réanimation-Brulés-CHU GUADELOUPE

    Pointe-à-Pitre, 97110

Other trials in Guadeloupe

About this study

Approximately 50 to 60% of ICU patients are subjected to invasive mechanical ventilation-through a tracheal tube. Extubation consists of a key moment for the patient on the road to recovery (1). The extubation failure, is a major disease event. The incidence of extubation failure vary between studies between 10% and 20% of ventilated patients over 48 hours, it is therefore a significant risk including at the individual level. Ultimately, it is observed higher mortality for patients with unsuccessful extubation and this independently of their overall severity (2,3). Among the complications associated with extubation failure observed the occurrence of nosocomial pneumonia. Large-scale epidemiological data, covering nearly half of French ICUs found a risk of nosocomial pneumonia multiplied by a factor of 3 in case of extubation failure. Observing this strong association between nosocomial pneumonia and extubation failure does not presage a causal link. In all cases the onset of pneumonia probably involved in the morbidity and mortality of patients undergoing a failed extubation(4).

Prevention of inhalation may limit congestion and bronchial and lung infection, and thereby reduce the risk of extubation failure. Indeed, the primary pathophysiologic mechanism responsible for nosocomial bronchopulmonary infection is inhalation of oropharyngeal and digestive secretions (5).

Read more

This risk of inhalation during intubation motivates the implementation of fasting prior to general anesthesia for elective surgery patients. Indeed, it is recommended to respect a 6-hour fast for solids and 2 hours for liquid (water, fruit juices without pulp, tea or coffee without milk) in this situation (9).

Although the situations are very different from the context of programmed anesthesia and extubation followed by a possible emergency reintubation on failure of extubation in the context of resuscitation, fasting appears as a potential means of limit the inhalation during the period of risk posed extubation and reintubation eventual resuscitation. Nevertheless, it is doubtful of the effectiveness of the single fasting to ensure gastric emptiness during the period of extubation. Indeed, a very large proportion of patients presents the delayed gastric emptying causing prolonged gastric fluid stasis. (10).

Fasting and aspiration of gastric contents through a stomach tube has not, to our knowledge, never been rigorously evaluated in the ICU extubation.

Moreover, the setting of fasting patients is likely to induce significant side effects first and foremost, a charge extra care for paramedics. The other major effect is the calorie deficit induced potential source of infectious complications and a delay in extubation.

Being tested
maintaining calorie intake, maximum gastric vacuity
Keywords
Airway Extubation/adverse effects/ Methods, Nutrition, Ventilator Weaning/methods, Intensive care Unit, Enteral Nutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • maintaining calorie intakeOther

    Maintaining enteral caloric intake at the same rate. No aspiration in the gastric tube.

  • maximum gastric vacuityOther

    stopping enteral feeding at least 6 hours before extubation. Suction in the gastric tube (if its caliber permits) continuously for 6 hours before extubation

Study groups in NCT03335345
Study groupRoleWhat they receive
maximum gastric voidOtherstopping enteral feeding at least 6 hours before extubation. Suction in the gastric tube (if its size permits) continuously for 6 hours before extubation.
Receives: Other: maximum gastric vacuity
maintaining calorie intakeOthermaintaining enteral caloric intake at the same rate. No aspiration in the gastric tube
Receives: Other: maintaining calorie intake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. reintubation within 7 days after extubation in intensive care.

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2017
  2. Study start5 Apr 2018
  3. Primary completion31 Dec 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,148 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03335345
Sponsor's protocol ID
CHM-2016/S3/07
Acronym
AMBROISIE
Status last verified
Mar 2022
First submitted
3 Nov 2017
Last updated
10 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Landais M, Nay MA, Auchabie J, Hubert N, Frerou A, Yehia A, Mercat A, Jonas M, Martino F, Moriconi M, Courte A, Robert-Edan V, Conia A, Bavozet F, Egreteau PY, Bruel C, Renault A, Huet O, Feller M, Chudeau N, Ferrandiere M, Rebion A, Robert A, Giraudeau B, Reignier J, Thille AW, Tavernier E, Ehrmann S; REVA network and CRICS-TriggerSEP F-CRIN research network. Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial. Lancet Respir Med. 2023 Apr;11(4):319-328. doi: 10.1016/S2213-2600(22)00413-1. Epub 2023 Jan 21.

    PubMed 36693402
  • Landais M, Nay MA, Auchabie J, Hubert N, Rebion A, Robert A, Giraudeau B, Reignier J, Thille AW, Tavernier E, Ehrmann S. Continuous enteral nutrition compared with a maximal gastric vacuity strategy at the time of extubation in the intensive care unit: protocol for a non-inferiority cluster randomised trial (the Ambroisie Project). BMJ Open. 2021 May 20;11(5):e041799. doi: 10.1136/bmjopen-2020-041799.

    PubMed 34016658

Questions about this trial

What is this clinical trial studying?

A study testing maintaining calorie intake and maximum gastric vacuity in people with Non-inferiority, in Terms of Extubation Failure, Continuation of Enteral Nutrition Before Extubation Versus Gastric Vacuity Peri-extubation, run by Centre Hospitalier le Mans at 22 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 22 sites in France, Guadeloupe. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

reintubation within 7 days after extubation in intensive care. (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03335345, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in